Headaches and the Nocebo Effect

Headache

Volumn 43, Issue 10, 2003, Pages 1113-1115

  Evans, Randolph W ^a   Rogers, Malcolm Porteous ^b  

^a Brigham and Women's Hospital ^*  (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Medications; Nocebo; Placebo; Side effects

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CYCLOPHOSPHAMIDE; NALOXONE; NOCEBO; OPIATE ANTAGONIST; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANXIETY; CASE REPORT; CHRONIC PAIN; CONDITIONING; DEPRESSION; DROWSINESS; DRUG INDUCED DISEASE; DYSPNEA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; MOOD DISORDER; MUSCLE WEAKNESS; NAUSEA; NOTE; POLYPHARMACY; PRIORITY JOURNAL; RISK; SIDE EFFECT; SOMATIZATION; SWEATING; TACHYCARDIA; VERTIGO;

ADULT; ANXIETY; DEPRESSION; DRUG THERAPY; FEMALE; HEADACHE DISORDERS; HUMANS; PLACEBO EFFECT; RISK FACTORS; SICK ROLE; SUGGESTION;

EID: 0347381128     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03216.x     Document Type: Note

References (12)

1. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Non-specific medication side-effects and the nocebo phenomenon. JAMA. 2002;287:622-627.
2. Rosenzweig P, Brohier S, Zipfel A. The placebo effect on healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies. Clin Pharmacol Ther. 1993;54:579-583.
3. The Treatment of Mild Hypertension Group. The treatment of mild hypertension study. Arch Intern Med. 1991;151:1413-1423.
4. Myers MG, Cairns JA, Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther. 1987;42:250-253.
5. Schweiger A, Parducci A. Nocebo: the psychologic induction of pain. Pav J Biol Sci. 1981;16:140-143.
6. Ferguson JM. Alprazolam XR: patient acceptability, safety, and tolerability. Psychiatr Ann. 1993;23:20-26.
7. Davis C, Ralevski E, Kennedy SH, Neitzert C. The role of personality factors in the reporting of side effect complaints to moclobemide and placebo. J Consult Clin Psychol. 1967;31:71-76.
8. Silberstein SD, Liu D. Drug overuse and rebound headache. Curr Pain Headache Rep. 2002;6:240-247.
9. Giang DW, Goodman AD, Schiffer RB, et al. Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci. 1996;8:194-201.
10. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19:484-494.
11. Luparello T, Lyons HA, Bleeker ER, McFadden ER, Jr. Influences of suggestion on airway reactivity in asthmatic subjects. Psychosom Med. 1968;30:819-825.
12. Moore N, Lecointre D, Noblet C, Mabille M. Frequency of cost of serious adverse drug reactions in a department of general medicine. Br J Pharmacol. 1998;45:301-308.